|
 |
 |
|
  |
|
|
 |
  |
  |
|
  |
  |
 |
 |
 |
 |
|
 |
 |
 |
 |
 |
 |
|
 |
 |
|
 |
Silver Lake Research is reinventing the way antibodies are made. Scientists at the company have invented a new process, called EAP (Enhanced Affinity Platform), to make very high affinity antibodies quickly and predictably, to almost any target. Unique technologies and processes based on EAP have allowed Silver Lake Research to develop patented antibody-based products for our own brand names as well as for our partners.
The EAP system has been applied to many difficult targets and has created a variety of previously unavailable monoclonal antibodies. Silver Lake Research is using its proprietary antibody production technology to rapidly and continuously expand its product portfolio through strategic partnerships and alliances.
Silver Lake Research recently expanded its research laboratories and manufacturing facilities in Southern California and, with these new capabilities, we look forward to serving our customers' future needs with an ever-expanding range of products. |
|
|
 |
 |
|
|
 |
|
|
|
 |
All contents © copyright
2008 Silver Lake Research, All rights reserved. |
|
 |